Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 5/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA4 | P22748 | 3/20 | 0.50 |
| ▸ | CA6 | P23280 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11882654 | 0.82 | PTPN1 (0.60) | PTPN1AKR1B1CA1CA2CA4 | |
| SCHEMBL6224574 | 0.82 | CA1 (0.65) | PTPN1AKR1B1CA1CA2CA4 | |
| SCHEMBL30479640 | 0.79 | PTPN1 (0.46) | PTPN1AKR1B1CA1CA2CA4 | |
| SCHEMBL9472226 | 0.79 | CA1 (0.68) | PTPN1AKR1B1CA1CA2CA4 | |
| SCHEMBL144299 | 0.79 | PTPN1 (0.46) | PTPN1AKR1B1CA1CA2CA4 | |
| SCHEMBL68947 | 0.77 | PTPN1 (0.54) | PTPN1AKR1B1CA1CA2CA4 | |
| Iodide SCHEMBL31484222 | 0.77 | PTPN1 (0.44) | PTPN1AKR1B1CA1CA2CA4 | |
| SCHEMBL516617 | 0.77 | CA1 (0.57) | PTPN1AKR1B1CA1CA2CA4 | |
| Hydrogen Sulfide SCHEMBL28189848 | 0.77 | PTPN1 (0.44) | PTPN1AKR1B1CA1CA2CA4 | |
| SCHEMBL19003619 | 0.76 | PTPN1 (0.44) | PTPN1CA1CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116354945-B | Fused imidazole carboxylic acid compound and preparation method and application thereof | 长春金赛药业有限责任公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-116354945-A | Fused imidazole carboxylic acid compound and preparation method and application thereof | 长春金赛药业有限责任公司 | 2023-06-30 | — | — | CN | disclosed |
| US-9981887-B1 | Synthesis of phenylethynylbenzenes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2018-05-29 | — | — | US | disclosed |
| US-9981887-B1 | Synthesis of phenylethynylbenzenes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2018-05-29 | — | — | US | disclosed |
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| US-8129493-B2 | Aromatic polyester | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | MURORAN INSTITUTE OF TECHNOLOGY (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110092662-A1 | AROMATIC POLYESTER | NITTA CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224343-A1 | MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME | F12, PHAX, WDR82 | PTPN1 3997/4885AKR1B1 1027/4885CA1 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.